ClinicalTrials.govpublic full text
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
esophageal cancer, gastric cancer (gc), gastroesophageal junction, fap, fibroblast activation protein, fibroblast activation protein inhibitor, fapi, gastroesophageal cancer, pet, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889858
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.